通用药品,监管方面,生物等价性调查和感知
Ravi Bhushan1, Jürgen Martens2
1Department of Chemistry, Indian Institute of Technology Roorkee, Roorkee, India.
Expert opinion on drug safety
|January 15, 2024
概括
监管机构应授权对仿制药进行立体选择性生物等价性研究,以确保赛米产品的性能. 这对于理解仿制药品质量和患者安全至关重要.
科学领域:
- 制药科学 制药科学
- 监管事务 监管事务
- 药理动力学 药理动力学
背景情况:
- 通用药品需要严格的生物等价性测试.
- 当前的法规可能无法完全解决通用API的刻板选择性方面.
- 了解racemic产品的性能对于市场批准至关重要.
研究的目的:
- 突出监管方面和药典在生物等价性调查中的重要性.
- 强调需要对仿制药的立体选择性生物等价性评估.
- 为了解决市场上racemic仿制品的表现.
主要方法:
- 文献综述包括USP专著,FDA要求和国际准则.
- 通过各种数据库进行搜索,包括PubMed,PubMed Central和WHO药物信息.
- 分析已公布的关于仿制药品活性成分 (API) 和药品检查的数据.
主要成果:
- 检查了仿制药API的生物等价性研究和监管要求 (USP,FDA).
- 确定了有关药品进出口检查问题的例子.
- 根据文献和监管标准,强调了立体选择性调查的必要性.
结论:
- 美国药典 (USP),美国食品和药物管理局 (USFDA) 和国际机构应该强制执行对通用API的立体选择性调查.
- 制药公司必须证明与标准相比,racemic仿制药的PK/PD参数相当.
- 全球执行这些法规对于患者护理和制药贸易至关重要.
更多相关视频
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
17.8K
09:30Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
3.4K
相关概念视频
Bioequivalence: Overview
1.0K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.0K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Control Governance: Regulatory Bodies and Their Impact
160
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
160
Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
129
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
129
Pharmacovigilance
835
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
835
